Michael Scolaro

Michael Scolaro

Sep 27, 2017

Group 6 Copy 117
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can hair loss be reversed with Oxy133, a sterol based drug candidate?

Hair loss can affect both men and women, often leaving a negative impact on the affected person’s life...

Can we use our immune cells to fight lung disease?

Acute respiratory distress syndrome (ARDS) is a common deadly illness often seen in the intensive care unit...

What's Calcium's role in heart and kidney disease?

Hardening of the arteries, or atherosclerosis, is a global problem leading to heart attacks and strokes...

Backer Badge Funded